Abacus Global Management, Inc. - Q1 2026 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended March 31, 2026. Abacus Global Management, Inc. (ABX) operates as a financial services firm specializing in alternative asset management, life settlement solutions, and technology services. The company is classified as an accelerated filer and a smaller reporting company. As of May 1, 2026, there were 95,922,367 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $59.39 million | $44.14 million |
| Net Income | $7.27 million | $5.40 million |
| Net Income Attributable to ABX | $7.27 million | $4.64 million |
| Diluted EPS | $0.07 | $0.05 |
| Operating Cash Flow | $91.69 million | ($61.59 million) |
| Cash and Equivalents | $37.21 million | $43.76 million |
| Total Debt (Principal) | $336.58 million | N/A |
| Adjusted EBITDA | $32.66 million | $24.51 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 34.6% year-over-year, driven primarily by a 39.3% surge in Life Solutions revenue ($50.57M vs. $36.30M). This was fueled by a significant increase in realized gains from policy sales, particularly to related parties ($16.55M vs. $0.90M).
- Profitability: Net income attributable to the company rose 56.6% to $7.27 million. Operating income decreased slightly to $18.33 million from $21.03 million due to higher operating expenses, but was offset by a reduction in non-operating losses (specifically the elimination of warrant liability losses and debt fair value gains seen in the prior year).
- Expense Increases: General and administrative expenses more than doubled to $25.87 million (up 111%), largely due to increased payroll from acquisitions, higher stock-based compensation ($6.34M vs. $2.36M), and legal fees. Sales and marketing expenses also rose 89.1% to $4.95 million.
- Cash Flow: Operating cash flow swung from a use of $61.59 million in Q1 2025 to a generation of $91.69 million in Q1 2026, primarily due to increased life policy settlement sales and changes in fair value adjustments.
- Debt Repayment: The company repaid approximately $77.85 million in debt during the quarter, significantly reducing the current portion of long-term debt.
Outlook, Risks, and Unusual Items
- Acquisitions: The company announced a $52.9 million acquisition of a minority position in Manning & Napier, expected to close in Q2 2026. Previous acquisitions of NIB and AccuQuote in 2025 contributed to increased headcount and revenue streams.
- Investment Volatility: The quarter included a $5.4 million unrealized gain on an equity investment and a $3.05 million impairment on a separate equity investment due to a failed business sale. These items are recorded in "Other income (expense), net."
- Related Party Transactions: A significant portion of Life Solutions revenue ($16.55M) and Asset Management revenue ($6.66M) is derived from related parties (Carlisle Funds, LP Funds). Management asserts these transactions are consistent with market terms.
- Stock Repurchases: The company repurchased 1.65 million shares for $14.45 million during the quarter. Approximately $9.74 million remains available under current repurchase programs.
- Valuation Sensitivity: The fair value of life settlement policies ($392.77M) is highly sensitive to discount rates. A 1% increase in the discount rate would decrease fair value by approximately $7.08 million.
Investor Verification Checklist
- Related Party Revenue Quality: Verify the sustainability of the 1,736% increase in related-party Life Solutions revenue and confirm the independence of pricing mechanisms.
- Debt Covenants: Review compliance with the Senior Secured Credit Facility (SSCF) covenants, specifically the Asset Coverage Ratio (reported at 3.24x) and leverage ratios.
- Policy Portfolio Turnover: Assess the impact of the high turnover ratio (1.9x) and the shift in sales mix toward related parties on future realized gains.
- Expense Trajectory: Monitor the sustainability of the 111% increase in G&A expenses, particularly the stock-based compensation component, against future revenue growth.
- Investment Impairments: Evaluate the risk exposure to the "Other Investments" portfolio, given the recent $3.05 million impairment and the 100% credit loss provision on a convertible note.